Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari
HSE National Clinical Guideline

National Clinical Guideline - Diagnosis, staging and treatment of patients with Gestational Trophoblastic Disease


Topic: Gestational trophoblastic disease
Document Owner: Evidence and Quality Hub, National Cancer Control Programme (NCCP)
National Group: Evidence and Quality Hub, National Cancer Control Programme
Effective From: 04 March 2026
Evidence-based recommendations on the diagnosis, staging and treatment of patients with gestational trophoblastic disease.
National Clinical Guideline - Diagnosis, staging and treatment of patients with Gestational Trophoblastic Disease
PDF, 1.59MB

The purpose of this National Clinical Guideline is to provide evidence-based recommendations on the diagnosis, staging and treatment of patients with gestational trophoblastic disease through the integration of the best research evidence with clinical expertise, patient values and experiences.

Back to HSE National Central Repository